Literature DB >> 3160658

Allostimulating cells in man. Quantitative variation in the expression of HLA-DR and HLA-DQ molecules influences T-cell activation.

G Nuñez, E J Ball, L K Myers, P Stastny.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3160658     DOI： 10.1007/bf00430597

Source DB:  PubMed          Journal:  Immunogenetics        ISSN： 0093-7711            Impact factor:   2.846


× No keyword cloud information.
  7 in total

1.  Antigen-presenting capabilities of human monocytes correlates with their expression of HLA-DS, an Ia determinant distinct from HLA-DR.

Authors:  T A Gonwa; L J Picker; H V Raff; S M Goyert; J Silver; J D Stobo
Journal:  J Immunol       Date:  1983-02       Impact factor: 5.422

2.  Different specificities of an HLA-DRw6 haplotype detected by alloreactive T lymphocytes.

Authors:  L K Myers; E J Ball; P Stastny
Journal:  Hum Immunol       Date:  1984-12       Impact factor: 2.850

3.  Characterization and expression of the HLA-DC antigens defined by anti-Leu 10.

Authors:  Y X Chen; R L Evans; M S Pollack; L L Lanier; J H Phillips; C Rousso; N L Warner; F M Brodsky
Journal:  Hum Immunol       Date:  1984-08       Impact factor: 2.850

4.  Functional significance of the regulation of macrophage Ia expression.

Authors:  D I Beller
Journal:  Eur J Immunol       Date:  1984-02       Impact factor: 5.532

5.  Expression of HLA-DR, MB, MT and SB antigens on human mononuclear cells: identification of two phenotypically distinct monocyte populations.

Authors:  G Nuñez; R C Giles; E J Ball; C K Hurley; J D Capra; P Stastny
Journal:  J Immunol       Date:  1984-09       Impact factor: 5.422

6.  Molecular localization of human class II MT2 and MT3 determinants.

Authors:  C K Hurley; R C Giles; G Nunez; R DeMars; L Nadler; R Winchester; P Stastny; J D Capra
Journal:  J Exp Med       Date:  1984-08-01       Impact factor: 17.579

7.  Immune response gene function correlates with the expression of an Ia antigen. II. A quantitative deficiency in Ae:E alpha complex expression causes a corresponding defect in antigen-presenting cell function.

Authors:  L A Matis; P P Jones; D B Murphy; S M Hedrick; E A Lerner; C A Janeway; J M McNicholas; R H Schwartz
Journal:  J Exp Med       Date:  1982-02-01       Impact factor: 14.307
  7 in total
  8 in total

1.  Complete nucleotide sequence characterization of DRB5 alleles reveals a homogeneous allele group that is distinct from other DRB genes.

Authors:  Konstantinos Barsakis; Farbod Babrzadeh; Anjo Chi; Kalyan Mallempati; William Pickle; Michael Mindrinos; Marcelo A Fernández-Viña
Journal:  Hum Immunol       Date:  2019-04-05       Impact factor: 2.850

2.  Immunoprevalence and magnitude of HLA-DP4 versus HLA-DR-restricted spontaneous CD4(+) Th1 responses against telomerase in cancer patients.

Authors:  Caroline Laheurte; Jeanne Galaine; Laurent Beziaud; Magalie Dosset; Jerome Kerzerho; Claire Jacquemard; Béatrice Gaugler; Christophe Ferrand; Anne Dormoy; François Aubin; Pascale Jacoulet; Virginie Westeel; Christophe Borg; Eric Tartour; Yann Godet; Bernard Maillère; Olivier Adotévi
Journal:  Oncoimmunology       Date:  2016-02-18       Impact factor: 8.110

3.  Multiple mismatches at the low expression HLA loci DP, DQ, and DRB3/4/5 associate with adverse outcomes in hematopoietic stem cell transplantation.

Authors:  Marcelo A Fernández-Viña; John P Klein; Michael Haagenson; Stephen R Spellman; Claudio Anasetti; Harriet Noreen; Lee Ann Baxter-Lowe; Pedro Cano; Neal Flomenberg; Dennis L Confer; Mary M Horowitz; Machteld Oudshoorn; Effie W Petersdorf; Michelle Setterholm; Richard Champlin; Stephanie J Lee; Marcos de Lima
Journal:  Blood       Date:  2013-04-17       Impact factor: 22.113

4.  Expression of major histocompatibility class II antigens by Langerhans' cells in cervical intraepithelial neoplasia.

Authors:  R G Hughes; M Norval; S E Howie
Journal:  J Clin Pathol       Date:  1988-03       Impact factor: 3.411

5.  Class II HLA mismatch improves outcomes following haploidentical transplantation with posttransplant cyclophosphamide.

Authors:  Scott R Solomon; Michael T Aubrey; Xu Zhang; Katelin C Jackson; Lawrence E Morris; H Kent Holland; Melhem M Solh; Asad Bashey
Journal:  Blood Adv       Date:  2020-10-27

Review 6.  Expression of MHC class II antigens in human B-cell leukaemia and non-Hodgkin's lymphoma.

Authors:  K Guy; A S Krajewski; A E Dewar
Journal:  Br J Cancer       Date:  1986-02       Impact factor: 7.640

7.  The Human Leukocyte Antigen-DPB1 Degree of Compatibility Is Determined by Its Expression Level and Mismatch Permissiveness: A German Multicenter Analysis.

Authors:  Daphne Mytilineos; Chrysanthi Tsamadou; Christine Neuchel; Uwe Platzbecker; Donald Bunjes; Natalie Schub; Eva Wagner-Drouet; Gerald Wulf; Nicolaus Kröger; Niels Murawski; Hermann Einsele; Kerstin Schaefer-Eckart; Sebastian Freitag; Jochen Casper; Martin Kaufmann; Mareike Dürholt; Bernd Hertenstein; Stefan Klein; Mark Ringhoffer; Carlheinz R Mueller; Sandra Frank; Hubert Schrezenmeier; Daniel Fuerst; Joannis Mytilineos
Journal:  Front Immunol       Date:  2021-01-25       Impact factor: 7.561

8.  HLA-DRB3/4/5 Matching Improves Outcome of Unrelated Hematopoietic Stem Cell Transplantation.

Authors:  Chrysanthi Tsamadou; Daphne Engelhardt; Uwe Platzbecker; Elisa Sala; Thomas Valerius; Eva Wagner-Drouet; Gerald Wulf; Nicolaus Kröger; Niels Murawski; Hermann Einsele; Kerstin Schaefer-Eckart; Sebastian Freitag; Jochen Casper; Martin Kaufmann; Mareike Dürholt; Bernd Hertenstein; Stefan Klein; Mark Ringhoffer; Sandra Frank; Christine Neuchel; Hubert Schrezenmeier; Joannis Mytilineos; Daniel Fuerst
Journal:  Front Immunol       Date:  2021-12-14       Impact factor: 7.561
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.